Chlorthalidone and Nasalcrom drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Chlorthalidone (chlorthalidone) and Nasalcrom (cromolyn sodium). Common drug interactions include omphalitis among females.

The phase IV clinical study analyzes what interactions people have when they take Chlorthalidone and Nasalcrom. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Chlorthalidone?

Chlorthalidone has active ingredients of chlorthalidone. It is often used in high blood pressure. eHealthMe is studying from 12,482 Chlorthalidone users. Check the latest studies of Chlorthalidone.

What is Nasalcrom?

Nasalcrom has active ingredients of cromolyn sodium. It is often used in allergies. eHealthMe is studying from 1,528 Nasalcrom users. Check the latest studies of Nasalcrom.



On Jul, 07, 2026

13 people who take Chlorthalidone and Nasalcrom together, and have interactions are studied.

Chlorthalidone and Nasalcrom drug interactions.

What are the common drug interactions of Chlorthalidone and Nasalcrom, by gender? *:

female:

  1. Omphalitis (medical term for infection of the umbilical cord)
  2. Diarrhoea
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Sinusitis (inflammation of sinus)
  5. Sinus disorder (disease of sinus)
  6. Viral infection

male:

n/a

What are the common drug interactions of Chlorthalidone and Nasalcrom, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Omphalitis (medical term for infection of the umbilical cord)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Diarrhoea
  4. Sinusitis (inflammation of sinus)
  5. Sinus disorder (disease of sinus)
  6. Viral infection

60+:

n/a

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 100.00%
  2. Mitral Valve Stenosis (narrowing of mitral valve): 9 people, 69.23%
  3. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 9 people, 69.23%
  4. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 9 people, 69.23%

* Approximation only. Some reports may have incomplete information.

Do you take Chlorthalidone and Nasalcrom?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Chlorthalidone and Nasalcrom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Chlorthalidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nasalcrom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Chlorthalidone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasalcrom and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on chlorthalidone and cromolyn sodium (the active ingredients of Chlorthalidone and Nasalcrom, respectively), and Chlorthalidone and Nasalcrom (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: